Partners
In 2024, SAFE-ID receives unrestricted educational grants for the annual programme from the following partners:
Financial support 2024
- GSK: 40'000 CHF
- ViiV Healthcare: 75'000 CHF
- Gilead: 50'000 CHF
- MSD: 50'000 CHF
- Astra Zeneca: 25'000 CHF
- Roche Diagnostics: 5'000 CHF
- Pfizer: 5'000 CHF
- Menarini: 5'000 CHF
All partners contribute to all educational events organised by SAFE-ID
Event Partner AstraZeneca is supporting the Challenge meeting, local meetings in Basel & Bern, all virtual sessions and the Special Session at SSI Annual meeting
Event Partners Pfizer and Roche are supporting the regional symposium in Berne.
Event Partner Menarini is supporting all Virtual Lunch sessions.